Literature DB >> 6310019

Epstein-Barr virus transformation of human pre-B cells.

M Hansson, K Falk, I Ernberg.   

Abstract

In vitro infection of human B lymphocytes with Epstein-Barr virus (EBV) results in establishment of B lymphoblastoid cell lines that reflect normal B cell phenotypes. In this study we have investigated whether immature B cells from fetal bone marrow and liver can serve as targets for EBV. The fetal bone marrow cells were readily transformed by EBV. Among the resulting cell lines, five were surface Ig (sIg)-negative. Three B cell-associated antigens defined by monoclonal antibodies were expressed to the same extent on the fetal cell lines, whether they belonged to the sIg- or sIg+ group. The various differentiation stages that these cell lines may represent are discussed.

Entities:  

Mesh:

Year:  1983        PMID: 6310019      PMCID: PMC2187354          DOI: 10.1084/jem.158.2.616

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Induction of EBNA precedes the first cellular S-phase after EBV-infection of human lymphocytes.

Authors:  L Einhorn; I Ernberg
Journal:  Int J Cancer       Date:  1978-02-15       Impact factor: 7.396

2.  Possibility of EB virus preferentially transforming a subpopulation of human B lymphocytes.

Authors:  C M Steel; J Philipson; E Arthur; S E Gardiner; M S Newton; R V McIntosh
Journal:  Nature       Date:  1977 Dec 22-29       Impact factor: 49.962

3.  Surface markers on human B and T lymphocytes. IV. Distribution of surface markers on resting and blast-transformed lymphocytes.

Authors:  M Jondal
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

4.  The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV.

Authors:  K Nilsson; G Klein; W Henle; G Henle
Journal:  Int J Cancer       Date:  1971-11-15       Impact factor: 7.396

5.  Immunofluorescent studies of the development of pre-B cells, B lymphocytes and immunoglobulin isotype diversity in humans.

Authors:  W E Gathings; A R Lawton; M D Cooper
Journal:  Eur J Immunol       Date:  1977-11       Impact factor: 5.532

6.  Characterization of a human B cell-specific antigen (B2) distinct from B1.

Authors:  L M Nadler; P Stashenko; R Hardy; A van Agthoven; C Terhorst; S F Schlossman
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

7.  Tumorigenicity of human hematopoietic cell lines in athymic nude mice.

Authors:  K Nilsson; B C Giovanella; J S Stehlin; G Klein
Journal:  Int J Cancer       Date:  1977-03-15       Impact factor: 7.396

8.  Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.

Authors:  G Miller; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

9.  Pre-B cells and other possible precursor lymphoid cell lines derived from patients with X-linked agammaglobulinemia.

Authors:  S M Fu; J N Hurley; J M McCune; H G Kunkel; R A Good
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

10.  Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes.

Authors:  M Jondal; G Klein
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

View more
  10 in total

1.  Growth of B95-8 cells and expression of Epstein-Barr virus lytic phase in serum-free medium.

Authors:  J E Shaw; R G Petit; K Leung
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency.

Authors:  M E Conley; A Lavoie; C Briggs; P Brown; C Guerra; J M Puck
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

3.  Effects of pure interferons on Epstein-Barr virus infection in vitro.

Authors:  J P Andersson; U G Andersson; I T Ernberg; S F Britton; M DeLey
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

4.  Maintenance of growth transformation with Epstein-Barr virus is mediated by secretion of autocrine growth factors in two serum-free B-cell lines.

Authors:  J E Shaw; L A Baglia; K Leung
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

5.  Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus.

Authors:  Christoph Mancao; Markus Altmann; Berit Jungnickel; Wolfgang Hammerschmidt
Journal:  Blood       Date:  2005-08-02       Impact factor: 22.113

Review 6.  Human monoclonal antibodies.

Authors:  S P Cole; B G Campling; T Atlaw; D Kozbor; J C Roder
Journal:  Mol Cell Biochem       Date:  1984-06       Impact factor: 3.396

7.  Human B cell colony growth from pre-B cells in vitro.

Authors:  A C Fay; A Trudgett; J M Thompson; T A McNeill
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

8.  Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growth-transforming program.

Authors:  Rosemary Tierney; Jasdeep Nagra; Isabel Hutchings; Claire Shannon-Lowe; Markus Altmann; Wolfgang Hammerschmidt; Alan Rickinson; Andrew Bell
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

9.  Low expression of human histocompatibility leukocyte antigen-DR is associated with hypermethylation of human histocompatibility leukocyte antigen-DR alpha gene regions in B cells from patients with systemic lupus erythematosus.

Authors:  H Sano; L J Compton; N Shiomi; A D Steinberg; R A Jackson; T Sasaki
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

10.  Restricted expression of Epstein-Barr virus latent genes in murine B cells derived from embryonic stem cells.

Authors:  Magdalena Zychlinska; Heidrun Herrmann; Ursula Zimber-Strobl; Wolfgang Hammerschmidt
Journal:  PLoS One       Date:  2008-04-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.